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Salmonella enterica serovar Typhi (S. Typhi), the etiological 
agent of enteric fever (typhoid fever), is a significant cause of 
morbidity in many parts of the world with poorly resourced 
health systems (Crump et al., 2004; Lozano et al., 2012), and 
among travelers (Jensenius et al., 2013; Leder et al., 2013).
Despite decades of research into typhoid fever patho-
genesis, neither the survival strategies of this intracellular bac-
terium in humans nor the intricacies of protective immune 
responses have been fully explained. S. Typhi invades the gut 
mucosa soon after ingestion, where it is taken up by macro-
phages and dendritic cells before transit to local lymph nodes. 
Within 24 h, a clinically insignificant blood stream infection 
is thought to disseminate the organism to the reticuloendo-
thelial system. Subsequently, a second, more sustained bacte-
remia can occur, which is accompanied by the onset of fever 
and constitutional symptoms (Parry et al., 2002; de Jong et al., 
2012). Significant evidence indicates bacterial immunomod-
ulatory capabilities, suggesting S. Typhi can effectively evade 
the host immune system (Wangdi et al., 2012), e.g., by expres-
sion of Vi-polysaccharide (Sharma and Qadri, 2004; Jansen et 
al., 2011) or inhibition of autophagy via mTOR activation 
(Tattoli et al., 2012). The clinical implications of immune eva-
sion include the observation that multiple episodes of typhoid 
infection are probably required to induce significant protec-
tion against natural infection (Saul et al., 2013).
We know little about when, where, or how the human 
immune system limits, and then clears, S. Typhi infection. 
Whereas immunological responses to Salmonella infection 
are characterized by IFN signatures (de Jong et al., 2012; 
Sztein et al., 2014), relatively low concentrations of pyrogenic 
cytokines, including IL-6, IL1β, and TNF, have been found 
in patients diagnosed with acute typhoid fever (Keuter et al., 
1994). Moreover, functional CD8+ T cells are activated by live 
oral vaccines and likely play a role in cell-mediated immunity 
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(CMI; Salerno-Goncalves et al., 2002; Sztein et al., 2014). Fi-
nally, as indicated by the efficacy of the parental Vi-polysac-
charide vaccine, antibodies also play a role in the protective 
host response to S. Typhi infection (Klugman et al., 1987). 
Despite this knowledge, the detailed mechanisms and how 
the different immunological aspects interact to produce effec-
tive immune responses are poorly understood.
Humans are the only known natural host of S. Typhi 
and, consequently, studies to elucidate immunopathogenesis 
have been compromised by the lack of suitable small animal 
models. To address this knowledge gap, we have recently es-
tablished a human infection model of typhoid fever in healthy 
adult volunteers based on early work (Hornick et al., 1970a; 
Levine et al., 2001; Waddington et al., 2014). In this study, 
we describe the longitudinal human host responses from the 
time of bacterial exposure until overt clinical disease devel-
ops, highlighting the potential to interrogate molecular dis-
ease pathogenesis using a human challenge model. Using 
integrative analysis of transcriptional and cytokine profiles, 
clinical outcome, and metabolite data, we build on previously 
reported response signatures to gain further insight into the 
complex disease pathogenesis of typhoid fever. Combining 
data derived from these analyses with data from macrophage 
and murine infection models highlight an association of the 
link between IFN responses and the tryptophan metabolism 
with clinical typhoid fever, providing novel insights into the 
immunopathogenesis of S. Typhi.
RES ULTS
Longitudinal blood transcriptome of participants 
challenged with S. Typhi
In this study, we orally challenged 41 healthy adults with S. 
Typhi in sodium bicarbonate solution, as described previ-
ously (Waddington et al., 2014); 61% (25/41) of whom were 
subsequently diagnosed with acute typhoid fever during a 
14-d challenge period. At the time of diagnosis, most partici-
pants had systemic symptoms, including fever and bacteremia 
(Waddington et al., 2014). Gene expression profiles were gen-
erated based on mRNA purified from whole blood before 
and at time points after challenge. In the blood of typhoid 
participants at diagnosis (time point: typhoid diagnosis [TD]), 
we detected marked differential expression from 24 h before 
(TD-24) to at least 24 h after diagnosis (TD+24; subsequently 
termed acute typhoid fever; Table S1). This perturbation in-
volved changes in the relative expression of 2,301–3,450 
transcripts (Student’s t test; Benjamini-Hochberg [BH], P < 
0.05; FC, ±1.5), which resolved in most participants by 14 d 
(D14) after challenge (Fig. 1 A).
As a comparative cohort, we analyzed transcriptional 
profiles from those individuals who did not develop typhoid 
fever despite oral challenge by measuring responses at 7 
(nD7) and 14 d (nD14) after challenge (Fig. 1 A). Although 
participants who appeared resistant during the challenge 
period were clinically inconspicuous, we detected mod-
erate differential expression of 335 genes (Student’s t test; 
BH, P < 0.05; FC, ±1.5) 7 d after challenge. Differential 
expression of these genes was indistinguishable from pre-
challenge levels by nD14 after challenge in these partici-
pants. Unsupervised clustering highlighted the significant 
differences between samples derived from participants with 
acute typhoid and the remaining samples (Fig. 1 A). Com-
parison of weighted molecular distance to health (MDTH) 
scores, a measure of transcriptional perturbation (Pankla et 
al., 2009), identified significant differences in transcriptional 
perturbation between samples taken during acute disease 
and samples taken at nD7 from participants who did not 
develop typhoid (Fig. 1 B).
IFN, cell cycle, and aryl hydrocarbon receptor signatures are 
differentially expressed during acute disease
To interpret the transcriptional changes observed after chal-
lenge, we searched our data for pathways and transcription 
factor (TF) binding sites over-represented in participants di-
agnosed with typhoid fever using the analysis tool InnateDB 
(Lynn et al., 2010). We observed a striking pattern of pathways 
representing type I and type II IFN signaling (Fig. 1 C). Fur-
thermore we observed a molecular signature of TFs associ-
ated with cell cycle control, including E2F complexes, DP-1, 
and Myc, in addition to those mediating IFN responses. We 
also detected overrepresentation of the TF aryl hydrocarbon 
receptor (AhR), previously shown to play a role in tumor 
biology (Opitz et al., 2011; Fig. 1, D–F).
Next, we compared our data to the transcriptome de-
rived from patients with blood culture–confirmed typhoid 
fever in Vietnam (n = 38), a region endemic for enteric fever 
(Thompson et al., 2009). Although we observed considerable 
heterogeneity between the Vietnam study and the challenge 
model at the gene level (33.3% overlap; Fig. S1 A), gene set 
enrichment analysis (GSEA) determined significant enrich-
ment of differentially expressed genes of the Vietnam data in 
the acute typhoid signature (Fig. S1 B). Moreover, similarities 
between the transcriptional responses to typhoid in the two-
study cohorts were supported when the data were analyzed at 
the pathway level (Fig. S1 C).
Modular analysis of the blood transcriptome confirms a 
dominant IFN signature during acute typhoid infection
To gain a more detailed insight into the nature of the tran-
scriptional response after challenge with S. Typhi, we mapped 
these data to a conceptual framework consisting of 62 pre-
defined transcriptional modules, as previously described 
(Chaussabel et al., 2008; Chaussabel and Baldwin, 2014).
Transcriptional dynamics during acute typhoid demon-
strated a significant relative overexpression of all three IFN 
modules (M1.2, M3.4, and M5.12). Furthermore, monocyte 
(M4.14), inflammatory (M4.6 and M5.1), and innate im-
mune modules (M3.2, M4.2, and M4.13) were also relatively 
overexpressed. In addition, we observed a moderate relative 
overexpression of neutrophil-related genes (M5.15) and sig-
nificant activation of apoptosis-related (M6.6 and M6.13) and 
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Figure 1. Transcriptional signatures associated with acute typhoid fever. (A) Unsupervised clustering of genes differentially expressed in samples 
derived in participants diagnosed or not diagnosed with typhoid after challenge. Color bar represents time points: nD7 (n = 14, green) and nD14 (n = 15, 
blue) in participants not diagnosed with typhoid; TD-24 h (n = 23), TD (n = 25), and TD+24 h (n = 22; acute disease, purple) and D14 (n = 19; red) in diag-
nosed participants. (B) MDTH scores based on the expression of the genes displayed in A. *, P < 0.05; ****, P < 0.0001 compared with challenge baselines 
(D0) using Kruskal-Wallis test with Dunn’s correction for multiple testing. (C) Top 20 most significant pathways overrepresented at TD (n = 25). (D–F) Top 
20 most significantly differentially expressed transcription factors at TD-24 h (n = 23; D), TD (n = 25; E), and TD+24 h (n = 22; F; red dotted line, P = 0.05). 
Euclidean distance clustering using the ward algorithm (A). Data are median with 25th/75th percentile (B). 
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cell cycle modules (M2.2, M3.3, M6.11, and M6.16; Fig. 2, A 
and B). In contrast, whereas modules do not reflect cell types 
directly, modules representing genes related to signaling and 
stimulation of B and T cells (M4.1, M4.10, and M4.15), the 
lymphoid lineage (M6.19) and NK cells (M3.6) were rela-
tively underexpressed during acute typhoid fever (Fig.  2, A 
and B) as were modules representing mitochondrial metabo-
lism and protein synthesis.
Several differences in transcriptional activity were ob-
served at nD7 when compared with those diagnosed with 
disease. Notably, whereas modules relating to IFN activity 
were not perturbed, those representing monocyte activation, 
Figure 2. Modular analysis of the acute typhoid transcriptome. (A) Modular maps were constructed at each time point separately as described in Ma-
terials and methods. Red or blue coloration indicates the proportion of over- or under-expressed transcripts (P < 0.05, unpaired Student’s t test) contained 
in each module, respectively (white, not expressed; blue, underexpressed; red, overexpressed). (top) Diagnosed participants at TD (n = 25) and D14 (n = 19); 
(bottom) participants who stayed well at nD7 (n = 14) and nD14 (n = 15). (B) Modular map annotation key. (C) Modular expression (in % significant genes) 
of each module was plotted ordered according to expression (positive to negative) at time of diagnosis (TD).
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inflammation, and the antimicrobial response, and some mod-
ules representing cell cycle genes, were inversely expressed 
compared with responses seen in participants with acute 
typhoid fever (Fig. 2 C).
Humans respond to S. Typhi within hours of ingestion
We previously showed that individuals who did not develop 
typhoid fever despite oral challenge failed to mount a signif-
icant anti–S. Typhi serological response (Waddington et al., 
2014). This raised the question of whether these participants 
experienced any significant host–S. Typhi interaction after in-
gestion, or whether challenge simply failed, perhaps as a result 
of bacterial destruction by gastric acid. Consequently, we de-
termined the longitudinal plasma cytokine response during 
the 14-d challenge period in all study participants (Tables S2 
and S3). Interestingly, we observed a significant induction of 
plasma cytokines, including sCD40L, fractalkine (CX3CL1), 
GROα, IL1RA, EGF, and VEGF, in the majority of partici-
pants 12 h after challenge (Fig. 3 A and Table S4). The mag-
nitude of this signal was dose dependent, had disappeared by 
24 h after challenge, and was not associated with subsequent 
development of typhoid fever (binary logistic regression and 
Cox proportional hazard models; Tables S5, S6, and S7).
To corroborate that the early cytokine signature was not 
associated with sodium bicarbonate (NaHCO3) used to neu-
tralize stomach acid before challenge, we performed a sub-
study in which healthy adult volunteers (n = 10) were given 
120 ml NaHCO3, omitting the bacterial suspension. Plasma 
cytokines were measured before and at 12 and 24 h after in-
gestion. NaHCO3 failed to induce any induction of measured 
cytokines (Fig. 3 B), indicating that these data represent a true 
early response signal attributable to S. Typhi ingestion.
Cytokine responses confirm blood transcriptome signatures 
during acute typhoid fever
As transcriptional responses were dominated by IFN-signa-
tures known to be associated with the intracellular pathogen 
S. Typhi (Thompson et al., 2009), we expected significant 
up-regulation of cytokines related to the IFN response. The 
peripheral blood cytokine profile of participants with acute 
typhoid fever was indeed dominated by IFN-γ related (IFN-γ 
and IP-10) and inflammatory cytokines such as TNF (Fig. 4, 
A–C; and Fig. S2, A–D). In contrast, volunteers who stayed 
well after challenge demonstrated no significant responses 
during the challenge period after disappearance of the early 
12-h cytokine signal (Fig. 4, D–F; and Fig. S2, E–H). Whereas 
these data mirror the transcriptional profile, they confirm 
previous findings from the field highlighting the sustained 
IFN-γ response during acute typhoid fever.
Modules associated with acute typhoid fever correlate 
with bacteremia and humoral responses in participants 
diagnosed with typhoid fever
A significant advantage of the human challenge model is 
the variety of study parameters available to relate molecular 
events with phenotypic outcomes. To investigate these rela-
tionships, we correlated weighted MDTH scores with mark-
ers of clinical disease and microbiological status in participants 
diagnosed with typhoid fever. MDTH scores were positively 
associated with maximal temperature change from baseline 
(ΔTemperaturemax), maximum CRP concentration (CRPmax), 
and duration of bacteremia (hours), but negatively associated 
with time-to-diagnosis (Fig.  5, A–D). As the magnitude of 
transcriptional perturbation was closely related to the clinical 
phenotype, we next aimed to dissect the transcriptome to ex-
plore potential relationships between specific gene expression 
patterns and outcome parameters. Correlation of modular 
expression (Obermoser et al., 2013) at TD with outcomes 
related to typhoid fever (including humoral responses and 
bacteremia; Waddington et al., 2014), identified a significant 
association between IFN-related gene overexpression and du-
ration of positive blood culture, implying a direct relationship 
between bacteremia and enhanced IFN response (Fig. 5 E). 
Modules representing general innate immune and inflam-
matory responses (IFN, inflammation, innate immunity, and 
apoptosis) were also positively associated with clinical markers 
of severity (including CRP levels and temperature), but neg-
atively associated with time-to-diagnosis. Furthermore, we 
observed significant correlations of several cell cycle modules 
with antibody levels at day 28 after challenge. Importantly, 
these modules were relatively underexpressed in participants 
who stayed well after challenge, a population that impor-
tantly failed to produce any notable anti–S. Typhi antibody 
responses, confirming that this signature appears to predict 
subsequent antibody responses to S. Typhi (Fig. 5 E).
Induction of the IFN–tryptophan metabolism interactome 
after challenge with S. Typhi
Although IFN responses during Salmonella infection are 
well described, are thought to originate from T and NK cells 
(Salerno-Goncalves et al., 2002), and are associated with in-
tracellular pathogens, this response is poorly understood, par-
ticularly in humans. Closer interrogation of the genes related 
to the observed IFN signature revealed many genes belonging 
to the guanylate-binding protein (GBP) family (previously 
linked to Salmonella infection; Meunier et al., 2014), and 
genes linking IFN-γ responses with the tryptophan metabo-
lism, including IDO1 (indoleamine 2,3-dioxygenase 1). This 
rate limiting enzyme in the tryptophan catabolism (Munn 
and Mellor, 2013) is co-regulated by the transcription factors 
STAT1 and IRF1 (Chon et al., 1996), and its activation leads 
to direct stimulation of the transcription factor AhR (Opitz 
et al., 2011), all three of which are over-represented during 
acute typhoid fever (Fig. 1, D–F). To visualize this molecular 
pathway, we custom curated the interactions between IFN-γ 
signaling, IDO1, and AhR using InnateDB and Cytoscape 
(Shannon et al., 2003; Lynn et al., 2010; "IFN–tryptophan 
interactome"). Superimposing this interactome with mean 
gene expression data after challenge indicated a profound dif-
ferential regulation of these genes during acute typhoid fever, 
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but not in those who stayed well after oral challenge (Fig. 6, A 
and B). Differential expression of key genes was confirmed by 
performing quantitative PCR on a subset of samples (Fig. S3). 
These data suggest a link between S. Typhi–associated IFN 
responses and the tryptophan catabolism.
The tryptophan catabolism is associated with 
bacteremia and clinical disease
We next sought to validate the activation of the tryptophan 
catabolism pathway by measuring key metabolites (trypto-
phan, kynurenine, and quinolate) in serum from challenge 
study participants. Kynurenine and quinolate levels were 
significantly increased at TD compared with prechallenge 
in those participants diagnosed with typhoid (P = 0.0001 
and P < 0.0001, respectively). Whereas tryptophan was not 
significantly decreased (P = 0.06; Fig.  6 C), none of these 
metabolites were changed at nD7 in those participants who 
stayed well after challenge (Fig.  6 D). Finally, linking these 
changes to disease outcome, key components of this path-
way, including IFN-γ, kynurenine, and quinolate changes, 
Figure 3. Plasma cytokine profiles within hours after challenge. Cytokine induction [log2 FC/D0] at prechallenge (D0), 12, 24, and 48 h after challenge 
in participants who were diagnosed (n = 25, dark gray) or stayed well (n = 16, light gray) after challenge with S. Typhi (A). Cytokine induction [log2 FC/D0] 
at 12 h, 24 h after ingestion of sodium bicarbonate solution (n = 10; B). Data are median with 25th/75th percentile and run in duplicates. **, P < 0.01; 
****, P < 0.0001; using unpaired Student’s t test (Table S4).
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were significantly correlated with the same microbiological 
(bacteremia) and clinical (ΔTemperaturemax) outcome param-
eters as observed for transcriptional IFN responses (Fig. 6 E). 
These results strongly suggest that activation of tryptophan 
catabolism is associated with the clinical disease pheno-
type of acute typhoid fever.
Expression of key genes mediating tryptophan catabolism 
during Salmonella infection in vivo
As it is impossible to investigate tissue-specific effects in the 
human challenge model, we sought to determine whether 
Salmonella infection induces key genes in the IFN–trypto-
phan signaling axis in a murine model. Thus, we orally chal-
lenged C57BL/6N mice with S. Typhimurium SL1344 or 
saline (controls, n = 5) and harvested cecum, liver, and spleen 
3 d (n = 4) and 7 d (n = 6) after infection. Marked induc-
tion of target genes involved in the IFN–tryptophan signaling 
was observed in most tissues, with the cecum and the liver 
showing the most consistent induction (Fig. 7 A). IDO1 was 
significantly expressed in the cecum at day 7 only, suggesting 
a time-dependent expression of these markers in vivo. To link 
the induction of these genes to IFN-γ signaling specifically, 
Figure 4. Longitudinal plasma cytokine profiles of participants challenged with S. Typhi. Longitudinal cytokine response profiles [log2 FC/D0] for par-
ticipants developing typhoid fever (A–C, n = 25) and those who were not diagnosed after challenge (D–F, n = 16). Data are median with 25th/75th percentile, 
and blue line depicts the mean. Each sample was run in duplicates. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using one-sample Student’s t test.
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Figure 5. Relationships among the blood transcriptome to clinically relevant outcomes. Spearman rank’s correlation analysis of weighted MDTH 
scores with (A) ΔTemperature (maximum change from baseline, n = 24), (B) maximum CRP (n = 24), (C) duration of bacteremia (in hours; n = 21), and (D) 
time-to-diagnosis (in hours; n = 25) in participants diagnosed with acute typhoid fever. (E) Modular expression (log10 FC) was calculated for each participant 
and correlated (Spearman’s rank correlation) with clinical and immunobiological outcome measures. Red, positive correlation; blue, negative correlation; 
bubble size represents correlation p-values.
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we infected IFN-γR KO mice (n = 6) and WT mice (n = 6) 
with S. Typhimurium SL1344 and monitored expression of 
IRF1, STAT1, IDO1, KYNU, and WARS once animals lost 
12% of their baseline body weight. All genes except KYNU 
were significantly down-regulated in IFN-γR KO but not 
WT mice (Fig. 7 B), confirming a critical role of IFN-γ in 
the induction of these genes in tissues typically infected by 
Salmonella after oral challenge.
Salmonella alone fails to induce key molecules of 
the tryptophan catabolism
Because macrophages are a primary target for Salmonella in-
vasion and IFN-γ, we sought to test whether the IFN-γ–
tryptophan signaling axis is induced in macrophages after 
stimulation with two Salmonella serovars (Typhi and Typh-
imurium). To this end, we extended the gene list of the inter-
actome in Fig. 6 to capture the broader IFN-γ signaling and 
tryptophan metabolism and validated its differential expres-
sion after human challenge (Fig.  7 C). Using a gentamicin 
protection assay (van Wilgenburg et al., 2013), protein abun-
dances corresponding to this gene list measured in IFN-γ–
primed macrophages after infection with S. Typhimurium 
showed a distinct clustering behavior compared with con-
trols, seemingly driven by the IFN-γ priming of macrophages 
(Fig. 7 C, inset). Specifically, key genes and proteins of the 
IFN-γ–tryptophan signaling axis were markedly up-regulated 
Figure 6. IFN–tryptophan interactome and metabolites after challenge. (A and B) Custom IFN–tryptophan metabolism interactome superimposed 
with the gene expression during acute disease (mean expression of TD-24 h [n = 23], TD [n = 25], and TD+24 h [n = 22]; A) and day 7 after challenge in 
those not diagnosed after challenge (nD7; n = 16; B). Kynurenine, tryptophan, and quinolinate changes from prechallenge control samples in participants 
diagnosed with typhoid (TD; n = 8; C) and those who stayed well (nD7; n = 7; D). (E) Spearman’s rank correlation of microbiological (bacteremia in hours) 
and clinical outcome parameters (ΔTemperaturemax) with IFN-γ (plasma cytokine; n = 10–11), kynurenine (n = 15), and quinolate (n = 15). Data are mean 
and 25th/75th percentile and samples were run in duplicates. Statistical differences were determined using paired Student’s t test (C and D).
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Figure 7. IFNγ-mediated IDO1 expression in vivo. (A) Gene expression was measured in spleen, cecum, and liver of WT mice at D0 (n = 5), day 3 (n = 
4), and day 7 (n = 6) after infection. (B) Gene expression was measured in spleen, cecum, and liver when WT (n = 6) and IFN-γR−/− (n = 6) mice experiencing 
12% weight loss PI. (C) Gene expression (log2 FC) of the IFN–tryptophan signaling network genes at day 7 (n = 16) and TD−24 h (n = 23), TD (n = 25), and 
TD+24 h (n = 22) in those who stayed well or were diagnosed after infection. (C, inset) Protein expression (log2 FC) in IFN-γ–primed macrophages alone (IFN; 
two independent experiments), infected with S. Typhimurium (IFN+STm; two independent experiments), or unprimed macrophages infected with Salmonella 
(STm; two independent experiments). Target gene (D) or protein (E) expression (log2 FC) in whole blood of participants challenged with S. Typhi (nD7, n = 
16; TD-24, n = 23; TD, n = 25; TD+24, n = 22) and macrophages stimulated with S. Typhimurium (two independent experiments), respectively. (F) Gene 
expression (log2 FC) of macrophages alone (unstim), infected with S. Typhi BRD948 (S. Typhi), IFN-γ–primed macrophages (IFN-γ), and INF-γ–primed and S. 
Typhi infected (IFNγ+BRD; two independent experiments/condition). (G) Unprimed macrophages were infected with S. Typhi BRD and IDO1 inhibitor alone 
o
n
 Septem
ber 22, 2016
D
ow
nloaded from
 
Published May 23, 2016
1071JEM Vol. 213, No. 6
in participants diagnosed after challenge in IFN-γ–primed 
macrophages in the presence of S. Typhimurium (Fig. 7, D 
and E). In addition, we complemented these results with stim-
ulation of macrophages with S. Typhi, validating the profound 
induction of the key genes in this pathway after IFN-γ prim-
ing (Fig. 7 F). Interestingly, a less profound induction of tar-
get genes and proteins was observed when macrophages were 
stimulated with Salmonella alone, indicating that the micro-
environment, including the presence of IFN-γ, is important 
in the regulation of this complex signaling network. Finally, to 
shed light on the impact of this signaling pathway on bacterial 
killing by macrophages, we monitored bacterial survival in 
IFN-γ–primed and unprimed macrophages with or without 
the IDO1 inhibitor INCB024360 (Liu et al., 2010). Whereas 
IFN-γ–primed macrophages were capable of killing S. Typhi, 
preincubation of macrophages with INCB024360 signifi-
cantly impaired bacterial killing. Interestingly, in unprimed 
macrophages, treatment with the inhibitor increased survival 
of intracellular Salmonella (Fig. 7 G), potentially due to acti-
vation of the IDO1 pathway by stimulation of innate immune 
receptors (Salazar et al., 2015). Collectively, these data suggest 
that IFN-γ induces key genes of the IFN-γ–tryptophan path-
way in macrophages infected with two different Salmonella 
serovars, and selective inhibition of IDO1 reduces the ability 
of these cells to contain bacterial growth.
DIS CUS SION
Infection with S. Typhi affects the lives of over 20 million peo-
ple worldwide each year, yet understanding of human disease 
pathogenesis remains limited (Hornick et al., 1970a,b). For 
the first time in over 40 yr, we used a highly controlled in-
fection model to study, in detail, human responses to S. Typhi, 
and relate these responses to the clinical and immunological 
phenotype. Using integrative analysis of multifaceted data, we 
describe a link between IFN responses and changes in me-
tabolites, highlighting for the first time the major role of host 
tryptophan metabolism in the immunopathogenesis and clini-
cal phenotype of typhoid fever.
Identifying early responses to infection with Salmonella 
has, to date, not been possible in the field setting. In our study, 
we observed significant induction of peripheral blood cyto-
kine production within the first 24 h after exposure, a time 
frame consistent with bacterial invasion of small bowel muco-
sal tissue. The association of early cytokine induction with the 
dose of bacterial exposure and the lack of correlation with 
subsequent diagnosis suggests that this response originates 
from the initial contact of S. Typhi with the intestinal mu-
cosa. Studies describing some of these cytokines as markers 
of intestinal inflammation and mucosal responses during in-
flammatory bowel disease (Beck and Podolsky, 1999; Danese 
et al., 2003) support these findings. These data give the first 
description of an early systemic cytokine response to infec-
tion with S. Typhi in humans.
In this study, we used whole-blood gene expression stud-
ies to interrogate in detail the human host responses of vol-
unteers experimentally infected with S. Typhi. Although we 
detected profound changes in gene expression during acute 
disease, participants who were not diagnosed also showed mild 
perturbation of gene expression 7 d after challenge. Notably, 
reanalysis of a published dataset highlighted marked simi-
larities between experimentally challenged participants and 
culture-confirmed typhoid fever patients in a field setting, 
indicating the direct relevance of our results to real-world 
typhoid in endemic settings (Thompson et al., 2009).
To gain insights into immune responses to acute ty-
phoid fever, we dissected the transcriptome using integra-
tive analysis and correlated gene expression patterns with 
specific clinical and immunobiological outcomes. Our data 
indicated a profound positive association between microbio-
logical outcomes and differential gene expression, suggesting 
that persistence of clinically relevant bacteremia drives much 
of the transcriptional change observed. Further dissection 
of the transcriptome indicated a significant relationship be-
tween cell cycle signatures and humoral responses 28 d after 
challenge. Interestingly, these gene signatures were under-
expressed in participants who stayed well after challenge, a 
population who did not exhibit any significant humoral re-
sponses. Activation of cell cycle signatures are associated with 
antibody responses after influenza vaccination (Bucasas et al., 
2011) and may be explained by a proliferative boost of anti-
gen-specific B cells in germinal centers (Gitlin et al., 2014). 
These findings are reflected in our transcriptome analysis, 
suggesting that this relationship holds true in real life infec-
tion with S. Typhi in humans.
The use of this challenge model enabled us to interro-
gate multiple facets of the host response to gain more detailed 
insight into the pathogenesis of typhoid fever. We observed 
a sustained IFN-related gene signature during acute typhoid 
disease in samples derived from the field and human chal-
lenge model, which was absent in participants who were not 
diagnosed after challenge. These data were confirmed at the 
cytokine level, likely reflecting the intracellular lifestyle of 
S. Typhi, driving an IFN-related phenotype associated with 
typhoid fever (Hess et al., 1996). Whereas IFN-γ responses 
have been associated with Salmonella infections (Lammas et 
al., 2000; MacLennan et al., 2004), we observed the over-
expression of genes linking IFN-γ signaling with the tryp-
tophan catabolism, mediated by IDO1. Capitalizing on the 
(INCB024360), after IFN-γ–priming (INF-γ), after IFN-γ priming and IDO1 inhibition (IFNγ+INCB024360) or alone (untreated), and bacterial counts were 
determined (three independent experiments/condition). At least three mice per group and time point were analyzed (A and B). Circles represent 95% CI (C). 
Data are mean FC over appropriate controls with 25th/75th percentile (A, B, and D–G). At least two independent experiments (C, inset, and E–G) with at least 
two biological repeats were performed. Q-PCRs were run in duplicates. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 using unpaired Student’s t tests.
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unique availability of serum samples collected after challenge, 
we observed significant alterations of metabolite levels down-
stream of IDO1. These were associated with bacteremia and 
clinical parameters, strongly suggesting activation of this path-
way and an involvement in disease pathogenesis. Intriguingly, 
Salmonella alone was unable to induce key molecules of this 
signaling pathway in macrophages unless exogenous IFN-γ 
was provided, suggesting an important role of IFN-γ in this 
event. Using a well-established murine model for Salmo-
nella infection, we confirmed the pivotal role of IFN-γ in 
the induction of genes involved in the tryptophan metabo-
lism after Salmonella infection in vivo. Notably, the first en-
zyme downstream of IDO1, KYNU, seemed to be inversely 
regulated in mice, indicating a more complex regulatory 
mechanism during infection.
Intriguingly, work from the last century reported the 
excretion of metabolites of the kynurenine pathway were de-
tected in the urine of patients with typhoid fever before the 
disease was recognized to be caused by Salmonella (Rapoport 
and Beisel, 1971). Subsequently, IDO1 and the tryptophan 
metabolism have been implicated in the response to infection 
with several pathogens (Yoshida et al., 1979; Fujigaki et al., 
2002; Silva et al., 2002; Peng and Monack, 2010; Blumenthal 
et al., 2012; Weiner et al., 2012; Niño-Castro et al., 2014), 
possibly to starve intracellular pathogens of their nutrients 
(Zhang and Rubin, 2013). Intriguingly, although IFN-γ–
primed macrophages effectively contain intracellular repli-
cation of S. Typhi, inhibition of IDO1 abrogated this effect. 
These data provide evidence that IDO1 may be involved in 
controlling intracellular Salmonella growth, possibly through 
decreasing tryptophan levels. Conversely, the consequent 
increase in kynurenine may modulate protective immune 
responses in vivo by activation of regulatory T cells, and in-
hibition of T cell proliferation (Munn et al., 1999; Sharma 
et al., 2007; Zelante et al., 2009), thus resulting in immuno-
modulatory effects. Indeed, we observed increased expression 
of gut-homing (α4β7 and CXCR3) and activation markers 
(PD-1) by regulatory T cells in PBMCs from participants 
during acute disease (compared with participants not diag-
nosed with typhoid) using an in vitro T cell stimulation assay 
(McArthur et al., 2015). Although more detailed experiments 
are warranted, our data suggest an underappreciated role of 
IDO1 activation and the host’s metabolism in the host re-
sponse to Salmonella infection.
Collectively, we demonstrated the usefulness of this 
unique model in investigating disease pathogenesis. Although 
the human challenge model limits us in providing definite 
proof of some mechanistic aspects, our data suggest import-
ant, novel aspects of S. Typhi infection, including previously 
unknown early responses to infection and an unappreciated 
role of IDO1 in the host response to Salmonella infection.
MAT ERI ALS AND MET HODS
Study design and participants. The present data were derived 
from clinical samples collected during the development of a 
human challenge model of typhoid fever using microbial dose 
escalation after obtaining informed consent (UKC RN ID 
9297; approval: Oxfordshire Research Ethics Committee A 
[10/H604/53]) as described previously (Waddington et al., 
2014). We used these samples to interrogate the host response 
to typhoid fever in a highly controlled experimental setting. 
Healthy, infection/vaccine-naive adult volunteers (partici-
pants; n = 41; age range, 19.4–46.5 yr) were challenged with 
a single oral dose of virulent S. Typhi (Quailes strain) bacteria 
suspended in 30 ml sodium bicarbonate solution [17.5 mg/
ml], and after pretreatment with 120 ml sodium bicarbonate 
solution to neutralize gastric acid. Oral challenge inocula 
were either low dose (n = 21; median [range] = 1.3 × 103 
CFU [0.7 × 103 – 1.8 × 103]) or high dose (n = 20; 1.98 × 
104 CFU [1.5 × 104 – 2.69 × 104]) and were administered 
after 90-min fasting. Participants were treated with oral anti-
biotics (ciprofloxacin, 500 mg twice daily, 14 d) at day 14 
(n = 16; those who did not develop typhoid disease in the 
first 14 d) after challenge unless diagnosed with acute typhoid 
infection, in which case treatment commenced immediately 
(n = 25; subsequently termed typhoid diagnosed or TD 
group). The TD group includes one participant who was 
withdrawn before day 14 after challenge in the original study 
(Waddington et al., 2014). Criteria for TD were either micro-
biological (≥1 positive blood culture collected after day 5) 
and/or clinical (fever ≥38°C sustained for ≥12 h). Partici-
pants were ambulatory and followed up as outpatients at least 
daily after challenge when safety, clinical, and laboratory mea-
surements were performed (Waddington et al., 2014).
A parallel bicarbonate substudy was performed in 
which 10 healthy adult volunteers ingested the same volume 
(120 ml, 17.5 mg/ml) of bicarbonate solution used for neu-
tralization of the stomach acid in the main study. Plasma sam-
ples were collected at 0, 12 and 24 h after ingestion, processed 
and stored at -80°C until further analysis.
Informed consent was obtained from all study volunteers.
Clinical parameters. Collection of clinical data includ-
ing temperature, blood pressure, and heart-rate, and elicita-
tion of symptoms was performed at each participant visit. 
C-reactive protein (CRP) concentrations were measured 
at the Oxford University Hospital NHS Trust laboratories 
by standard procedures, whereas daily blood cultures were 
performed as previously described and in accordance with 
national standard operating procedures (England, 2011, 2013; 
Waddington et al., 2014).
Gene expression arrays sample processing. Peripheral venous 
blood (3 ml) was collected in Tempus Blood RNA tubes (Ap-
plied Biosystems) before challenge (baseline, prechallenge 
controls, D0; n = 40), 24 h before TD (TD-24, n = 23; TD 
group only), at TD (n = 25; median day of diagnosis = day 7; 
median day of symptoms = day 7), at 24 h after TD (TD+24, 
n = 22), and 14 d after challenge (D14, n = 19). In those who 
did not develop typhoid fever, gene expression was measured 
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at day 7 (nD7; n = 14) and day 14 (nD14; n = 16) after chal-
lenge. Total RNA was extracted from all samples using the 
Tempus Spin RNA Isolation kit (Life Technologies). 50 ng of 
RNA was used for hybridization into Illumina HT-12v4 
bead-arrays (Illumina) at the Wellcome Trust Sanger Institute 
(Hinxton, England, UK) and fluorescent probe intensities 
were captured with GenomeStudio software (Illumina).
Data processing and identification of differentially expressed 
genes. Gene transcription responses to infection with wild-
type S. Typhi were assessed by analysis of changes in tran-
script abundance in whole-blood samples collected during 
the study. For each time-point, blood transcriptome profiles 
were generated by comparing levels of expression to the me-
dian of the respective baseline control group. All samples were 
quantile normalized and background subtracted using the 
Bioconductor suite in R (Version 3.0.1; Gentleman et al., 
2004). For gene level analysis, probes denoted as low quality 
(illuminaHumanv4.db) were removed and batch correction 
was applied where necessary using the Combat algorithm 
(Leek et al., 2012). Data were filtered for detection (P value 
≤ 0.05 in ≥ 60% of samples), and filtered probes were then 
used for subsequent gene level analysis (t test corrected for 
multiple testing using BH, P < 0.05; absolute fold-change 
(FC), ≥1.5). Data have been deposited at ArrayExpress under 
accession no. E-MTAB-3423.
Modular level analysis. Modular analysis is a systems-scale 
strategy for microarray analysis that has identified transcrip-
tional modules formed by genes coordinately expressed across 
multiple disease datasets, thus allowing functional interpreta-
tion of the microarray data into biologically useful informa-
tion. A detailed account of how modules were derived and 
the module-based mining analysis strategy has been reported 
elsewhere (Banchereau et al., 2012; Chaussabel and Baldwin, 
2014). Modules were deemed activated or suppressed if ≥10% 
genes per module were significantly (P < 0.05) over- (red) or 
underexpressed (blue) compared with prechallenge control 
samples (Chaussabel et al., 2008). Mean module expression 
was used as a measure of activation and determined by calcu-
lating the mean modular FC expression per sample over con-
trols at a given time points. Percentage expression of each 
module was identified as the number of over- or underex-
pressed transcripts divided by the total number of genes con-
tained in a given module.
Gene expression data typhoid patients in Vietnam. We used 
publically available data from a study conducted in Vietnam in 
2011 (available from Gene Expression Omnibus under acces-
sion no. GSE7000; Thompson et al., 2009). The data used were 
all healthy control (n = 16) samples, as well as samples from 
acute, culture-confirmed typhoid patients 1 d (D1; n = 38) or 
3 d (D3; n = 25) after admission to hospital (Thompson et al., 
2009). We illustrated the overlap between statistically differen-
tially expressed genes in the Vietnam and the challenge study 
dataset (BH, P < 0.05; FC, ±1.25) using a Venn diagram (Fig. 
S1 A). To compare the data statistically, we performed GSEA 
in R using three custom gene sets derived from the Vietnam 
data. These consisted of all differentially expressed genes, only 
down- or up-regulated genes (BH, P < 0.05; FC, ±1.25).
Heat maps and MDTH scores. As a measure of transcriptional 
perturbation, weighted MDTH scores (Pankla et al., 2009) 
were calculated for each sample based on the relevant signa-
tures used by performing outlier analyses on a gene-by-gene 
basis. Dispersion of baseline control expression values was 
used to determine whether the values of a given sample and 
time point (e.g., TD) lay inside or outside the baseline control 
mean ± 2SD (Pankla et al., 2009). The heat map in Fig. 1 A 
was constructed based on genes significantly differentially ex-
pressed (BH, P < 0.05; FC, ±1.5) at TD and day 7 (nD7) after 
challenge in those who stayed well throughout the challenge 
period, yielding 2,128 genes after duplicates were removed 
(Euclidean distance, ward clustering).
Pathway overrepresentation analysis and custom interactome 
analysis. Pathway and transcription factor overrepresentation 
analysis was performed on up-regulated (BH, P < 0.01; FC, 
>1.5) and differentially expressed genes (BH, P < 0.01; FC, 
±1.5), respectively, at given time points using the publically 
available overrepresentation tool InnateDB (Lynn et al., 
2010). Overrepresentation analysis of the Vietnam dataset was 
performed using genes up-regulated at days 1 and 3 (BH, P < 
0.01; FC, >1.5). The InnateDB analysis algorithm searches 
several databases including KEGG, Reactome, Nethpath, PID 
NCI, Biocarta, and INOH.
A custom network was built by merging the IFN-
signaling pathway (Reactome ID: 13077), and the experi-
mentally established interactions of IDO1 and AhR as 
curated within InnateDB (Lynn et al., 2010) using Cytoscape 
(Shannon et al., 2003). The interactome was then annotated 
with transcriptional data from the human challenge model; 
nodes that were not expressed at all were removed. A gene 
list was constructed representing genes belonging to the 
custom interactome, broader annotation of the IFN signaling 
(Reactome ID: 13077, 18059, and 13074) and the tryptophan 
metabolism (KEGG :00380). Individual fold-change (FC) 
gene expression (all challenged volunteers; Fig.  7  C) and 
protein expression values of macrophage stimulations (two 
independent experiments) of all genes in this list that were 
present in the proteomics data were used to perform a 
principle component analysis (Fig. 7 C, inset).
Quantitative PCR. Quantitative PCR was performed on tar-
get genes of interest in a subset of samples at prechallenge 
baselines, TD, and day 7 after challenge in those who did not 
develop typhoid fever during the 14-d challenge period, and 
animal tissue or macrophage RNA as indicated. 30 ng RNA 
was assayed using the TaqMan RNA-to-Ct 1-Step kit (Life 
Technologies) using TaqMan Gene Expression Assays for tar-
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get genes (Life Technologies), following the manufacturer’s 
instructions. Fold-change values over prechallenge baselines 
were calculated using the ΔΔCt method using GAP DH as a 
housekeeping gene (Table S8).
Cytokine assays. Plasma was separated from 3 ml peripheral 
venous blood collected in heparinized tubes, treated with 
proteinase inhibitor, and stored at −80°C. Cytokine concen-
trations were measured in 50 µl plasma using a custom 18-
plex Luminex panel (Table S2; MIL LIP LEX MAP kit; 
Millipore) according to the manufacturer’s instructions. Each 
sample was measured in duplicate and samples with a %CV 
value >30% were excluded, unless the concentration was be-
tween 3.2 and 6.4 pg/ml (two times lower limit of detection 
[LLD]), in which case 40% was accepted. Cytokine concen-
trations below the analytes specificity range were set to 50% 
of that range, unless the value was below the LLD, in which 
case the concentration was set to 1.6 pg/ml (50% LLD).
Induced pluripotent stem (iPS) cell–derived human macro-
phages. Undifferentiated human iPS cells were maintained 
on a monolayer of mitotically inactivated mouse embry-
onic feeder (MEF) cells in advanced Dulbecco’s modified 
Eagles/F12 medium (DMEM/F12) supplemented with 
20% knockout replacement serum (KSR), l-Glutamine 
(2 mM), β-mercaptoethanol (0.055 mM), and 8 ng/ml re-
combinant human FGF2 (R&D Systems) and differentiated 
as prescribed previously (van Wilgenburg et al., 2013). Fully 
differentiated macrophages were primed overnight with 20 
ng/ml IFN-γ. On the day of infection, cells were washed 
with PBS and S. Typhi BRD948 (Ty2 ΔaroA, ΔaroC, 
ΔhtrA) or S. Typhimurium SL1344 (MOI = 10:1) or IFN-γ 
(20 ng/ml) was added and incubated at 37°C for 1 h. Un-
primed cells were also stimulated using S. Typhi BRD948 
or S. Typhimurium SL1344 (MOI = 10:1) for 1  h. Cells 
were washed three times and incubated with media con-
taining 50 µg/ml gentamicin to remove extracellular bacte-
ria. After 1  h cells were washed again and fresh medium 
added. After 4 h, cells were harvested and snap frozen for 
proteomics analysis, or lysed for RNA extraction or bacte-
rial plating. For inhibitor experiments, IDO1 inhibitor 
INCB024360 was added at 250 nM final concentration 
16 h before stimulation.
Animal experiments. WT C57BL/6N mice were infected 
with 104 CFU S. Typhimurium SL1344 grown to log-phase, 
whereas naive controls received 200 µl PBS (n = 5) by oral 
gavage. Mice were culled at day 3 (n = 4) and 7 (n = 6) after 
infection, and cecum, liver, and spleen harvested for RNA 
extraction and gene expression analysis by qPCR.
Ifngr1tm1Agt mice were obtained from The Jackson Lab-
oratory and backcrossed 10 times onto a C57BL/6J back-
ground (hereafter referred to as IFN-γR KO). Six IFN-γR 
KO mice and six WT mice (in-house) were infected with 104 
CFU S. Typhimurium SL1344 and monitored daily. Animals 
were culled when 12% weight loss was observed and cecum, 
spleen, and liver harvested for RNA extraction. Mice were 
bred and maintained in accordance with UK Home Office 
regulations under the project license 80/2596. This license 
was reviewed by The Wellcome Trust Sanger Institute Ani-
mal Welfare and Ethical Review Body (AWE RB). Mice were 
matched for age and sex in each experiment.
Human iPS-derived macrophage proteomics. Two biological 
replicates of iPS-derived macrophages from unstimulated and 
stimulated conditions (IFN-γ, Salmonella typhimurium 
[STm], and IFN-γ+STm) were lysed and equal amounts of 
protein extracts were reduced, alkylated and digested with 
trypsin. The resultant peptides were labeled with the TMT 
reagents (Thermo Fisher Scientific) according to a modified 
manufacturer’s protocol. The peptide mixture was fraction-
ated with basic reverse phase chromatography over a 35-min 
gradient program. The liquid chromatography mass spec-
trometry analysis of the individual fractions was performed 
on the Dionex Ultimate 3000 UHP LC system coupled with 
the LTQ Orbitrap Velos mass spectrometer (Thermo Fisher 
Scientific) with a top5 collision induced dissociation high-
er-energy collisional dissociation sequential activation 
method. The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium (Vizcaíno et 
al., 2014) via the PRI DE partner repository with the data-
set identifier PXD001953.
Human iPS-derived macrophage data analysis. The acquired 
mass spectra were submitted to SequestHT search engine im-
plemented on the Proteome Discoverer 1.4 software for pro-
tein identification and quantification against a UniProt fasta 
file containing 20,190 Human reviewed entries. Peptide false 
discovery rate was set at 0.01 and validation was based on 
q-value and decoy database search. The analysis resulted in the 
identification of 20,784 unique peptides attributed to 4,399 
unique protein groups of which 4,071 were fully quantified 
for all the conditions. Protein ratios against the untreated 
sample were log2-transformed and median values for the two 
biological replicates were calculated for each protein. A total 
of 118, 103, and 136 proteins were found up-regulated >2SD 
of all protein medians and 58, 55, and 36 proteins were found 
down-regulated <2SD of all protein medians for the IFN-γ, 
Stm, and IFN-γ+Stm treatments, respectively.
Antibody responses. Serological data were measured as de-
scribed by Waddington et al. (2014). In brief, antibody titers 
in serum against flagellin (H-d–antigen) and lipopolysaccha-
ride (O–antigen) were measured by ELI SA at baseline and 
day 28 after challenge.
Metabolite analysis in serum. Kynurenine, quinolate, and 
tryptophan levels were determined in serum of a subset of 
participants (TD, n = 8; nTD, n = 7). The metabolites were 
determined by LC/MS performed by Metabolon Inc. FCs 
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were generated from median scaled Area Under the Curve 
(AUC) values (missing values imputed).
Statistical analysis. For analysis of the cytokine induction at 
12  h after challenge, 12  h cytokine concentrations (pg/ml) 
were compared with baseline values (unpaired Student’s t test; 
Table S4). Linear regression models were fitted to determine 
the relationship between all cytokines and dose adjusting for 
baseline (Table S5). Binary logistic regression and Cox propor-
tional hazard models were fitted for all cytokines to determine 
whether cytokine induction at 12 h predicted subsequent TD 
or time to diagnosis (Tables S6 and S7). In the proportional 
hazards model participants without the event (TD) were cen-
sored at day 14 after challenge. For analysis of metabolite 
changes, a paired Student’s t test (two-sided) was used to de-
termine significant changes from baseline and time point of 
interest. FCs of kynurenine (TD or nD7 over D0) and quinio-
late (TD or nD7 over D0) were correlated with IFN-γ (TD-
24 h or nD7 over D0), duration of bacteremia (hours), and 
maximum temperature change from baseline (ΔTemperature-
max). All other statistical tests used are stated in figure legends 
and the text. Statistical analysis was performed using GraphPad 
Prism v6 or R (Version 3.0.1).
Online supplemental material. Fig. S1 compares acute typhoid 
fever responses in the challenge model with patients from the 
field. Fig. S2 shows the cytokine responses after challenge. Fig. 
S3 shows the qPCR validation of array data. Table S1 indicates 
differential expressed genes at specific time points. Table S2 
shows the time points cytokines were measured. Table S3 
provides a summary statistic of cytokine data. Table S4 shows 
p-values for cytokines at 12 h after challenge. Tables S5–S7 
shows statistical modeling between cytokine response at 12 h 
after challenge and several outcome variables. Table S8 
indicates primers used in qPCR experiments. Online 
supplemental material is available at http ://www .jem .org /cgi 
/content /full /jem .20151025 /DC1.
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